Papers › migraines › 7864374

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Lancet (London, England) · 17-2-2018 · 7864374 on PMC →

434 citations FWCI 30.05 Lymphoma Diagnosis and Treatment Trend

Citation data as of 2026-04-12 (OpenAlex).

Extracted findings

This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 7864374 is in the queue.

In the meantime: Browse migraines papers → · Ask about this topic → · Explore the graph →